
5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively
Author(s) -
Daniel Gackowski,
Maciej Gawroński,
Cassandra M Kerr,
Tomas Radivoyevitch,
Ewelina Zarakowska,
Marta Starczak,
Abdulkadir Abakir,
Alexey Ruzov,
Jaroslaw P. Maciejewski,
Ryszard Oliński
Publication year - 2019
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2019.224030
Subject(s) - myelodysplastic syndromes , surrogate endpoint , medicine , cancer research , oncology , genetics , biology , bone marrow